AACC uses Cookies to ensure the best website experience. Continuing without changing Cookie settings assumes you consent to our use of cookies on this device. You can change these settings at any time, but that may impair functionality on our websites. Review our cookie and privacy policy

Kfir Oved, Ph.D. M.D. and Eran Eden, Ph.D.

Eran Eden, Ph.D. (MeMed CEO and co-Founder)

Dr. Eden has been the CEO of MeMed since its inception in 2009, leading it through several financing rounds and rapid growth. He has 13 years of combined business and academic experience leading cutting-edge interdisciplinary technologies that synergize molecular biology and informatics. Dr. Eden holds a B.Sc. in Computer Engineering, B.A. in Biology, and M.Sc. in Computer Science (all Cum Laude) from the Technion, Israel Institute of Technology, and a Ph.D. in Systems Biology from the Weizmann Institute of Science. Dr. Eden is co-author of 8 patents and 13 peer-reviewed publications and is the recipient of multiple awards including the prestigious GE and Science Prize for Promising Life Scientists.

Kfir Oved, Ph.D. M.D. (MeMed CTO and co-Founder)

Dr. Oved has 13 years of combined industry and academic experience, leading interdisciplinary projects that apply molecular immunology-based technologies to clinical applications. Dr. Oved holds a B.A. in Biology (Summa Cum Laude), B.Sc. in medicine (Magna Cum Laude), Ph.D. in molecular immunology, and M.D. from the Medical School at the Technion, Israel Institute of Technology. He served as scientific advisor at Applied Immune Technologies (AIT) Inc., is co-author of 6 patents, the author of 8 peer-reviewed publications, and the recipient of multiple awards including the prestigious Wolf Award for research students.